Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2022-12-12 00:00:00 ET · period of report 2022-12-08 · accession 0001209191-22-060691 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-12 | 2022-12-08+ | CADL | Amello Jason | CFO | P - Purchase | $1.80 | +5,568 | 3,100 | New | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-09 | P | A | 2,468 | $1.93 | 5,568 | D | — | — | (F2) The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.85 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-12-08 | P | A | 3,100 | $1.69 | 3,100 | D | — | — | (F1) The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.78. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |